12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

C1qScreen regulatory update

One Lambda Inc., part of Thermo Fisher, received CE Mark approval for C1qScreen assay for use in transplant diagnostic...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >